Clinical Trial Update: A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 clinical trial assessing the pharmacokinetic properties of NN1218 formulations in subjects with Type 1 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NN1218

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED